Search results

Search for "multidrug-resistant bacteria" in Full Text gives 5 result(s) in Beilstein Journal of Organic Chemistry.

Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment

  • Anas J. Rasras,
  • Mohamed El-Naggar,
  • Nesreen A. Safwat and
  • Raed A. Al-Qawasmeh

Beilstein J. Org. Chem. 2022, 18, 631–638, doi:10.3762/bjoc.18.63

Graphical Abstract
  • the development of multidrug resistant bacteria due to excessive use of antibiotics [2][4]. Heterocyclic compounds are the key components for drug design and synthesis. Among them, 1,3,4-oxadiazole derivatives are attractive and have been investigated for decades. This is due to their promising
PDF
Album
Supp Info
Full Research Paper
Published 31 May 2022

Protein–protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics

  • Laura Carro

Beilstein J. Org. Chem. 2018, 14, 2881–2896, doi:10.3762/bjoc.14.267

Graphical Abstract
  • to develop novel anti-infective drugs which can combat the ever-increasing rate of multidrug-resistant bacteria. This review describes the progress achieved towards the discovery of molecules that disrupt PPI systems in bacteria for which inhibitors have been identified and whose targets could
  • pneumoniae, penicillin-non-susceptible Haemophilus influenzae, ampicillin-resistant Shigella spp., fluoroquinolone-resistant Given the prevalence of antibacterial drug-resistant pathogens, one viable and promising strategy to combat these multidrug-resistant bacteria is the development of antibiotic
PDF
Album
Review
Published 21 Nov 2018

Synthesis of a leopolic acid-inspired tetramic acid with antimicrobial activity against multidrug-resistant bacteria

  • Luce Mattio,
  • Loana Musso,
  • Leonardo Scaglioni,
  • Andrea Pinto,
  • Piera Anna Martino and
  • Sabrina Dallavalle

Beilstein J. Org. Chem. 2018, 14, 2482–2487, doi:10.3762/bjoc.14.224

Graphical Abstract
  • class of antibacterial agents active also against resistant strains. Keywords: antimicrobial activity; multidrug-resistant bacteria; natural products; synthesis; tetramic acid; Introduction The treatment of bacterial infections by antibiotics is widely regarded as one of the major achievements of the
  • 20th century. However, the continued emergence of multidrug-resistant bacteria, mainly due to the abuse of antimicrobial molecules (e.g., for treatment of bacterial skin diseases [1]), emphasises the urgent need for novel antibiotic families. In this regard, natural products are privileged compounds
PDF
Album
Supp Info
Letter
Published 24 Sep 2018

Antibacterial structure–activity relationship studies of several tricyclic sulfur-containing flavonoids

  • Lucian G. Bahrin,
  • Henning Hopf,
  • Peter G. Jones,
  • Laura G. Sarbu,
  • Cornelia Babii,
  • Alina C. Mihai,
  • Marius Stefan and
  • Lucian M. Birsa

Beilstein J. Org. Chem. 2016, 12, 1065–1071, doi:10.3762/bjoc.12.100

Graphical Abstract
  • of one of the greatest problems faced by modern medicine: multidrug-resistant bacteria. Resistance may arise via various mechanisms including changes in cell-wall permeability, target site mutation, antibiotic inactivation and the development of efflux pumps that transport the drugs out of the cell
PDF
Album
Supp Info
Full Research Paper
Published 23 May 2016

Advances in synthetic approach to and antifungal activity of triazoles

  • Kumari Shalini,
  • Nitin Kumar,
  • Sushma Drabu and
  • Pramod Kumar Sharma

Beilstein J. Org. Chem. 2011, 7, 668–677, doi:10.3762/bjoc.7.79

Graphical Abstract
  • of the growing emergence of antimicrobial resistance are major concerns to the public health and scientific communities worldwide, especially in the field of multidrug- resistant bacteria and fungi [1][2]. These trends have emphasized the urgent need for new, more effective, less toxic and safe
PDF
Album
Review
Published 25 May 2011
Other Beilstein-Institut Open Science Activities